Board of Scientific Counselors, National Center for Injury Prevention and Control, 80305 [2023-25456]
Download as PDF
<![CDATA[
Federal Register / Vol. 88, No. 221 / Friday, November 17, 2023 / Notices
reasonable likelihood that such
radiation doses may have endangered
the health of members of this class.
Matters To Be Considered: The agenda
will include discussions on the
following: NIOSH Program Update;
Department of Labor (DOL) Program
Update; Department of Energy (DOE)
Program Update; Special Exposure
Cohort (SEC) Petitions Update;
Background and Update on
Subcommittee for Procedures Review
Activities; Pinellas Workgroup Update,
Metals and Control Workgroup Update,
Dose Reconstruction Review Methods
Workgroup Update, and a Board Work
Session. Agenda items are subject to
change as priorities dictate.
The Director, Office of Strategic
Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2023–25460 Filed 11–16–23; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Board of Scientific Counselors,
National Center for Injury Prevention
and Control
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of closed meeting.
AGENCY:
In accordance with regulatory
provisions, the Centers for Disease
Control and Prevention (CDC)
announces the following meeting for the
Board of Scientific Counselors, National
Center for Injury Prevention and Control
(BSC, NCIPC or Board). This meeting is
partially open to the public.
DATES: The meeting will be held on
January 11, 2024. The first session of the
day will be held from 10 a.m. to 12:05
p.m., EST (OPEN), and the second
session will be held from 1 p.m. to 4:30
p.m., EST (CLOSED). The public
comment period will be at the end of
khammond on DSKJM1Z7X2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
18:57 Nov 16, 2023
Jkt 262001
the open session of the meeting, from
11:45 a.m. to 12:00 p.m., EST.
ADDRESSES: Webinar, Atlanta, Georgia.
All participants must register by using
the following link to attend the open
session: https://cdc.zoomgov.com/
meeting/register/vJItf-igpjopGsXuGU
hsdlIOmRCB2yx509k.
FOR FURTHER INFORMATION CONTACT:
Christopher R. Harper, Ph.D.,
Designated Federal Officer, Board of
Scientific Counselors, National Center
for Injury Prevention and Control,
Centers for Disease Control and
Prevention, 4770 Buford Highway NE,
Mailstop S–1069, Atlanta, Georgia
30341. Telephone: (404) 718–8330;
Email: ncipcbsc@cdc.gov.
SUPPLEMENTARY INFORMATION: Portions
of the meeting referenced above will be
closed to the public in accordance with
provisions set forth in Section
552b(c)(4) and (6), Title 5, U.S.C., and
the Determination of the Director, Office
of Strategic Business Initiatives, Office
of the Chief Operating Officer, Centers
for Disease Control and Prevention,
pursuant to 5 U.S.C. 1009 (Pub. L. 92–
463, as amended).
Purpose: The Board of Scientific
Counselors, National Center for Injury
Prevention and Control (BSC, NCIPC or
Board) will: (1) conduct, encourage,
cooperate with, and assist other
appropriate public health authorities,
scientific institutions, and scientists in
the conduct of research, investigations,
experiments, demonstrations, and
studies relating to the causes and
strategies related to the prevention of
injury, overdose, and violence; (2) assist
States and other entities in preventing
intentional and unintentional injuries,
and to promote health and well-being;
and (3) make recommendations of grants
and cooperative agreements for research
and prevention activities related to
injury, overdose, and violence. The
BSC, NCIPC makes recommendations
regarding policies, strategies, objectives,
and priorities and reviews progress
toward injury, overdose, and violence
prevention. The Board also provides
advice on the appropriate balance of
intramural and extramural research and
provides guidance on the needs,
structure, progress, and performance of
intramural programs. Further, the Board
provides guidance on extramural
scientific program matters.
Additionally, the Board provides
second-level scientific and
programmatic review of applications for
research grants, cooperative agreements,
and training grants related to injury,
overdose, and violence prevention, and
recommends approval of projects that
merit further consideration for funding
PO 00000
Frm 00037
Fmt 4703
Sfmt 4703
80305
support. The Board also provides
feedback and input on strategic plans,
resources, and priority publications
related to injury, overdose, and violence
prevention.
Matters To Be Considered: The open
session of the meeting will include a
discussion on the updated Intimate
Partner Violence Research Priorities.
The closed session of the meeting will
focus on the secondary peer review of
extramural research grant applications
received in response to one (1) Notice of
Funding Opportunity: RFA–CE–24–
001—‘‘Grants for Injury Control
Research Centers.’’ Agenda items are
subject to change as priorities dictate.
The Director, Office of Strategic
Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2023–25456 Filed 11–16–23; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2023–N–4807]
General Hospital and Personal Use
Devices Panel of the Medical Devices
Advisory Committee; Notice of
Meeting; Establishment of a Public
Docket; Request for Comments—506J
Device List
AGENCY:
Food and Drug Administration,
HHS.
Notice; establishment of a
public docket; request for comments.
ACTION:
The Food and Drug
Administration (FDA) announces a
forthcoming public advisory committee
meeting of the General Hospital and
Personal Use Devices Panel of the
Medical Devices Advisory Committee
(the Committee). The general function of
the Committee is to provide advice and
recommendations to FDA on regulatory
issues. The meeting will be open to the
public. FDA is establishing a docket for
public comment on this document.
SUMMARY:
E:\FR\FM\17NON1.SGM
17NON1
]]>Agencies
[Federal Register Volume 88, Number 221 (Friday, November 17, 2023)]
[Notices]
[Page 80305]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-25456]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Board of Scientific Counselors, National Center for Injury
Prevention and Control
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of closed meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with regulatory provisions, the Centers for
Disease Control and Prevention (CDC) announces the following meeting
for the Board of Scientific Counselors, National Center for Injury
Prevention and Control (BSC, NCIPC or Board). This meeting is partially
open to the public.
DATES: The meeting will be held on January 11, 2024. The first session
of the day will be held from 10 a.m. to 12:05 p.m., EST (OPEN), and the
second session will be held from 1 p.m. to 4:30 p.m., EST (CLOSED). The
public comment period will be at the end of the open session of the
meeting, from 11:45 a.m. to 12:00 p.m., EST.
ADDRESSES: Webinar, Atlanta, Georgia. All participants must register by
using the following link to attend the open session: https://cdc.zoomgov.com/meeting/register/vJItf-igpjopGsXuGUhsdlIOmRCB2yx509k.
FOR FURTHER INFORMATION CONTACT: Christopher R. Harper, Ph.D.,
Designated Federal Officer, Board of Scientific Counselors, National
Center for Injury Prevention and Control, Centers for Disease Control
and Prevention, 4770 Buford Highway NE, Mailstop S-1069, Atlanta,
Georgia 30341. Telephone: (404) 718-8330; Email: [email protected].
SUPPLEMENTARY INFORMATION: Portions of the meeting referenced above
will be closed to the public in accordance with provisions set forth in
Section 552b(c)(4) and (6), Title 5, U.S.C., and the Determination of
the Director, Office of Strategic Business Initiatives, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
pursuant to 5 U.S.C. 1009 (Pub. L. 92-463, as amended).
Purpose: The Board of Scientific Counselors, National Center for
Injury Prevention and Control (BSC, NCIPC or Board) will: (1) conduct,
encourage, cooperate with, and assist other appropriate public health
authorities, scientific institutions, and scientists in the conduct of
research, investigations, experiments, demonstrations, and studies
relating to the causes and strategies related to the prevention of
injury, overdose, and violence; (2) assist States and other entities in
preventing intentional and unintentional injuries, and to promote
health and well-being; and (3) make recommendations of grants and
cooperative agreements for research and prevention activities related
to injury, overdose, and violence. The BSC, NCIPC makes recommendations
regarding policies, strategies, objectives, and priorities and reviews
progress toward injury, overdose, and violence prevention. The Board
also provides advice on the appropriate balance of intramural and
extramural research and provides guidance on the needs, structure,
progress, and performance of intramural programs. Further, the Board
provides guidance on extramural scientific program matters.
Additionally, the Board provides second-level scientific and
programmatic review of applications for research grants, cooperative
agreements, and training grants related to injury, overdose, and
violence prevention, and recommends approval of projects that merit
further consideration for funding support. The Board also provides
feedback and input on strategic plans, resources, and priority
publications related to injury, overdose, and violence prevention.
Matters To Be Considered: The open session of the meeting will
include a discussion on the updated Intimate Partner Violence Research
Priorities. The closed session of the meeting will focus on the
secondary peer review of extramural research grant applications
received in response to one (1) Notice of Funding Opportunity: RFA-CE-
24-001--``Grants for Injury Control Research Centers.'' Agenda items
are subject to change as priorities dictate.
The Director, Office of Strategic Business Initiatives, Office of
the Chief Operating Officer, Centers for Disease Control and
Prevention, has been delegated the authority to sign Federal Register
notices pertaining to announcements of meetings and other committee
management activities, for both the Centers for Disease Control and
Prevention and the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2023-25456 Filed 11-16-23; 8:45 am]
BILLING CODE 4163-18-P
